Furthermore, FOXC1 is not known to be actively expressed in normal cells but is highly expressed in pancreatic cancer cells, which is key for its potential to become a novel therapeutic target for pancreatic cancer. The gene discussed is FOXC1; the disease is familial pancreatic carcinoma.